References
- Arias JL. (2011). Drug targeting strategies in cancer treatment: an overview. Mini Rev Med Chem, 11:1–17.
- Liu Y, Miyoshi H, Nakamura M. (2007). Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer, 120:2527–2537.
- Faraji AH, Wipf P. (2009). Nanoparticles in cellular drug delivery. Bioorg Med Chem, 17:2950–2962.
- Sinha R, Kim GJ, Nie S, Shin DM. (2006). Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther, 5:1909–1917.
- Chavanpatil MD, Khdair A, Panyam J. (2006). Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. J Nanosci Nanotechnol, 6:2651–2663.
- Jiang W, Kim BY, Rutka JT, Chan WC. (2008). Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol, 3:145–150.
- Decuzzi P, Ferrari M. (2008). The receptor-mediated endocytosis of nonspherical particles. Biophys J, 94:3790–3797.
- Kasuya T, Kuroda S. (2009). Nanoparticles for human liver-specific drug and gene delivery systems: in vitro and in vivo advances. Expert Opin Drug Deliv, 6:39–52.
- Fallon RJ, Schwartz AL. (1989). Receptor-mediated delivery of drugs to hepatocytes. Adv Drug Deliv Rev 4:49–63.
- Wu J, Nantz MH, Zern MA. (2002). Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front Biosci, 7:d717–d725.
- Cho CS, Kobayashi A, Takei R, Ishihara T, Maruyama A, Akaike T. (2001). Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers. Biomaterials, 22:45–51.
- Liang HF, Yang TF, Huang CT, Chen MC, Sung HW. (2005). Preparation of nanoparticles composed of poly(gamma-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by HepG2 cells. J Control Release, 105:213–225.
- Yoo MK, Kim IY, Kim EM, Jeong HJ, Lee CM, Jeong YY et al. (2007). Superparamagnetic iron oxide nanoparticles coated with galactose-carrying polymer for hepatocyte targeting. J Biomed Biotechnol, 2007:94740.
- Kobayashi K, Sumitomo H. (1985). Synthesis and functions of polystyrene derivatives having pendant oligosaccharides. Polym J, 17:567–575.
- Feng SS, Mu L, Win KY, Huang G. (2004). Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr Med Chem, 11:413–424.
- Singla AK, Garg A, Aggarwal D. (2002). Paclitaxel and its formulations. Int J Pharm, 235:179–192.
- Wu L, Tang C, Yin C. (2010). Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Drug Dev Ind Pharm, 36:439–448.
- Wang X, Li J, Wang Y, Cho KJ, Kim G, Gjyrezi A et al. (2009). HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. ACS Nano, 3:3165–3174.
- Hua MY, Yang HW, Chuang CK, Tsai RY, Chen WJ, Chuang KL et al. (2010). Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer. Biomaterials, 31:7355–7363.
- Xu Z, Gu W, Huang J, Sui H, Zhou Z, Yang Y et al. (2005). In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int J Pharm, 288:361–368.
- Sahoo SK, Panyam J, Prabha S, Labhasetwar V. (2002). Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release, 82:105–114.
- Ruckenstein E, Manciu M. (2003). Specific ion effects via ion hydration: II. Double layer interaction. Adv Colloid Interface Sci, 105:177–200.
- Budhian A, Siegel SJ, Winey KI. (2007). Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm, 336:367–375.
- Dubernet C. (1995). Thermoanalysis of microspheres. Thermochimica, 248:259–269.
- Hans ML, Lowman AM. (2002). Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mat Sci 6:319–327.
- Mu L, Feng SS. (2003). PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharm Res, 20:1864–1872.